111 Net Income 2018-2023 | YI

111 net income from 2018 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
111 Annual Net Income
(Millions of US $)
2023 $-55
2022 $-60
2021 $-105
2020 $-70
2019 $-72
2018 $-55
2017 $-38
111 Quarterly Net Income
(Millions of US $)
2023-12-31 $-30
2023-09-30 $-13
2023-06-30 $-8
2023-03-31 $-5
2022-12-31 $-15
2022-09-30 $-14
2022-06-30 $-14
2022-03-31 $-17
2021-12-31 $-19
2021-09-30 $-39
2021-06-30 $-25
2021-03-31 $-22
2020-12-31 $-23
2020-09-30 $-16
2020-06-30 $-13
2020-03-31 $-18
2019-12-31 $-22
2019-09-30 $-17
2019-06-30 $-15
2019-03-31 $-18
2018-09-30 $-18
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.111B $2.105B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $37.366B 20.52
Inspire Medical Systems (INSP) United States $4.612B 0.00
Axonics (AXNX) United States $3.446B 0.00
Hims & Hers Health (HIMS) United States $3.129B 0.00
10x Genomics (TXG) United States $2.980B 0.00
Olink Holding AB (publ) (OLK) Sweden $2.978B 0.00
IRhythm Technologies (IRTC) United States $2.950B 0.00
Enovis (ENOV) United States $2.875B 21.31
Azenta (AZTA) United States $2.743B 154.15
Privia Health (PRVA) United States $2.016B 112.67
Schrodinger (SDGR) United States $1.654B 0.00
Omnicell (OMCL) United States $1.398B 48.32
Phreesia (PHR) United States $1.393B 0.00
Standard BioTools (LAB) United States $0.746B 0.00
Fulgent Genetics (FLGT) United States $0.662B 0.00
Definitive Healthcare (DH) United States $0.649B 0.00
Talkspace (TALK) United States $0.467B 0.00
Clover Health Investments (CLOV) United States $0.442B 0.00
Health Catalyst (HCAT) United States $0.410B 0.00
Pulmonx (LUNG) United States $0.349B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.296B 0.00
Butterfly Network (BFLY) United States $0.217B 0.00
P3 Health Partners (PIII) United States $0.191B 0.00
Outset Medical (OM) United States $0.187B 0.00
American Well (AMWL) United States $0.145B 0.00
TruBridge (TBRG) United States $0.134B 7.19
MSP Recovery (LIFW) United States $0.107B 0.00
SHL Telemedicine (SHLT) Israel $0.075B 0.00
Future Health ESG (FHLT) United States $0.070B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.064B 0.00
Augmedix (AUGX) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) China $0.054B 0.00
CareCloud (CCLD) United States $0.045B 0.00
Movano (MOVE) United States $0.042B 0.00
Akili (AKLI) United States $0.034B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.031B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.020B 0.00
Cue Health (HLTH) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Syra Health (SYRA) United States $0.010B 0.00
Biotricity (BTCY) United States $0.010B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.001B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00